Sec. 2. Reauthorization of the C.W. Bill Young Cell Transplantation Program
264 words·~1 min read·
/bill/114/hr/2820/eas/section-2A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 379(d)(2)(B) of the Public Health Service Act ( 42 U.S.C. 274k(d)(2)(B) ) is amended— by striking remote collection and inserting collection ; and by inserting including remote collection, after cord blood units, . Section 379B of the Public Health Service Act ( 42 U.S.C. 274m ) is amended— by striking $30,000,000 for each of fiscal years 2011 through 2014 and ; and by inserting and $30,000,000 for each of fiscal years 2016 through 2020 before the period at the end. The Secretary of Health and Human Services, in consultation with the Director of the National Institutes of Health, the Commissioner of the Food and Drug Administration, and the Administrator of the Health Resources and Services Administration, including the Advisory Council on Blood Stem Cell Transplantation established under section 379(a) of the Public Health Service Act ( 42 U.S.C. 274k(a) ), and other stakeholders, where appropriate given relevant expertise, shall conduct a review of the state of the science of using adult stem cells and birthing tissues to develop new types of therapies for patients, for the purpose of considering the potential inclusion of such new types of therapies in the C.W.
Bill Young Cell Transplantation Program (established under such section 379) in addition to the continuation of ongoing activities. Not later than June 30, 2019, the Secretary shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives recommendations on the appropriateness of such new types of therapies for inclusion in the C.W. Bill Young Cell Transplantation Program.
Connectionstraces to 2
Traces to 2 documents
Citation graph
cites case law
Cites 2Cited by 0 across 0 sources